Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.alpalabs.in | |
Market Cap | 110.04 Cr. | |
Enterprise Value(EV) | 116.35 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 2.15 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | 24.27 | Trailing Twelve Months Ending 2022-12 |
Industry PE | 32.00 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 56.48 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 0.93 | Calculated using Price: 52.30 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 2.10 Cr. | 21,040,600 Shares |
FaceValue | 10 | |
Company Profile | ||
Alpa Laboratories, incorporated in 1988, is engaged in the business of manufacturing pharmaceutical products. In 1967, the company started its journey as a partnership concern with Purushottam R Patel, M S Chawla and Pravin C Shah as the founding partners. Later on March 18, 1988 the company became a private limited company and a decade later it became a public limited enterprise. |
1 Day |
|
+3.01% |
1 Week |
|
-4.42% |
1 Month |
|
-8.25% |
3 Month |
|
-15.92% |
6 Month |
|
-11.88% |
1 Year |
|
-24.42% |
2 Year |
|
+43.29% |
5 Year |
|
+34.45% |
10 Year |
|
+557.86% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | -5.84 | -1.60 | 7.61 | 2.68 | 2.92 | 1.03 | 1.86 | 6.97 | 12.29 | |
Return on Capital Employed (%) | -2.54 | -0.89 | 9.61 | 6.59 | 5.47 | 3.26 | 3.09 | 10.42 | 16.81 | |
Return on Assets (%) | -4.07 | -1.10 | 4.99 | 1.86 | 2.29 | 0.84 | 1.54 | 5.56 | 9.53 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 88 | 87 | 93 | 95 | 98 | 98 | 100 | 108 | 122 | 114 | |
Non Curr. Liab. | 6 | 0 | 1 | 0 | 0 | 0 | -1 | 0 | 5 | 12 | |
Curr. Liab. | 32 | 41 | 52 | 30 | 23 | 22 | 21 | 33 | 29 | 30 | |
Minority Int. | |||||||||||
Equity & Liab. | 127 | 128 | 146 | 125 | 121 | 121 | 120 | 140 | 155 | 157 | |
Non Curr. Assets | 74 | 16 | 27 | 20 | 23 | 27 | 25 | 19 | 16 | 16 | |
Curr. Assets | 53 | 113 | 119 | 105 | 98 | 94 | 95 | 121 | 139 | 140 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 127 | 128 | 146 | 125 | 121 | 121 | 120 | 140 | 155 | 157 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 57 | 57 | 54 | 63 | 63 | 78 | 86 | 98 | 112 | 88 | |
Other Income | 1 | 3 | 6 | 5 | 5 | 5 | 3 | 4 | 11 | 12 | |
Total Income | 57 | 61 | 59 | 69 | 68 | 83 | 89 | 102 | 123 | 101 | |
Total Expenditure | -51 | -55 | -47 | -56 | -59 | -77 | -83 | -90 | -102 | -89 | |
PBIDT | 6 | 6 | 12 | 12 | 9 | 6 | 6 | 12 | 21 | 12 | |
Interest | -2 | -2 | -1 | -2 | -1 | -1 | 0 | 0 | 0 | 0 | |
Depreciation | -9 | -6 | -1 | -3 | -3 | -3 | -3 | -1 | -2 | -1 | |
Taxation | 0 | 1 | -3 | -3 | -2 | -2 | -1 | -4 | -5 | -5 | |
Exceptional Items | -1 | -2 | |||||||||
PAT | -5 | -1 | 7 | 3 | 3 | 1 | 2 | 7 | 14 | 5 | |
Minority Interest | |||||||||||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | -5 | -1 | 7 | 3 | 3 | 1 | 2 | 7 | 14 | 5 | |
Adjusted EPS | -2 | -1 | 3 | 1 | 1 | 0 | 1 | 3 | 7 | 2 |
Particulars | 9 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 8 | -2 | -22 | 17 | -13 | -1 | 18 | -2 | 2 | |
Cash Fr. Inv. | -2 | 37 | -8 | -2 | -11 | -15 | -11 | 6 | -16 | |
Cash Fr. Finan. | 4 | 7 | -6 | -15 | 9 | -5 | -1 | 0 | 5 | |
Net Change | 10 | 42 | -36 | 0 | -15 | -20 | 5 | 4 | -8 | |
Cash & Cash Eqvt | 10 | 53 | 17 | 37 | 21 | 1 | 6 | 11 | 3 |
Tue, 14 Feb 2023
Financial Results Of The Company For Quarter And Nine Months Ended On 31St December 2022. Alpa Laboratories Limited has submitted the Un-Audited Standalone & Consolidated Financial Results of the Company for Quarter and Nine Months ended on 31st December 2022. |
Fri, 03 Feb 2023
Board Meeting Intimation for The Quarter Ended On 31St December 2022 ALPA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve the Standalone and Consolidated Unaudited Financial Results for the Quarter ended on 31st December 2022. |
Sat, 21 Jan 2023
Clarification sought from Alpa Laboratories Ltd The Exchange has sought clarification from Alpa Laboratories Ltd on January 20 2023 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded. The reply is awaited. |
Tue, 28 Mar 2023 |
|
|
|
|
|